| 0 |
CFTR GENE MUTATION |
19 |
0.7600 |
| 1 |
CYTOMEGALOVIRUS URINARY TRACT INFECTION |
13 |
0.4194 |
| 2 |
TONIC POSTURING |
14 |
0.2295 |
| 3 |
BILE ACIDS INCREASED |
39 |
0.2203 |
| 4 |
RESPIRATORY TRACT MALFORMATION |
28 |
0.2105 |
| 5 |
PHILADELPHIA POSITIVE CHRONIC MYELOID LEUKAEMIA |
15 |
0.1562 |
| 6 |
PULMONARY MALFORMATION |
42 |
0.1197 |
| 7 |
BILIARY CIRRHOSIS |
21 |
0.1045 |
| 8 |
HAEMOSIDEROSIS |
24 |
0.0896 |
| 9 |
BLOOD ALKALINE PHOSPHATASE ABNORMAL |
77 |
0.0856 |
| 10 |
VENOOCCLUSIVE DISEASE |
188 |
0.0750 |
| 11 |
CHOLESTASIS OF PREGNANCY |
34 |
0.0739 |
| 12 |
PRIMARY BILIARY CHOLANGITIS |
34 |
0.0723 |
| 13 |
LUNG CYST |
27 |
0.0687 |
| 14 |
PARENTERAL NUTRITION |
15 |
0.0649 |
| 15 |
VENOOCCLUSIVE LIVER DISEASE |
279 |
0.0564 |
| 16 |
BILIARY CIRRHOSIS PRIMARY |
18 |
0.0520 |
| 17 |
DEVICE RELATED BACTERAEMIA |
15 |
0.0484 |
| 18 |
CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION |
43 |
0.0482 |
| 19 |
CHOLANGITIS SCLEROSING |
96 |
0.0467 |
| 20 |
VANISHING BILE DUCT SYNDROME |
51 |
0.0457 |
| 21 |
LACTATION DISORDER |
22 |
0.0451 |
| 22 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
238 |
0.0437 |
| 23 |
APLASTIC ANAEMIA |
225 |
0.0430 |
| 24 |
POOR SUCKING REFLEX |
17 |
0.0428 |
| 25 |
PORTAL HYPERTENSIVE GASTROPATHY |
24 |
0.0426 |
| 26 |
GAMMA-GLUTAMYLTRANSFERASE ABNORMAL |
25 |
0.0415 |
| 27 |
COMPLICATIONS OF TRANSPLANTED LIVER |
14 |
0.0388 |
| 28 |
DISSEMINATED ASPERGILLOSIS |
18 |
0.0381 |
| 29 |
BILE DUCT STENOSIS |
43 |
0.0359 |
| 30 |
BILIARY TRACT INFECTION |
22 |
0.0354 |
| 31 |
RED BLOOD CELL TRANSFUSION |
14 |
0.0341 |
| 32 |
ASPARTATE AMINOTRANSFERASE ABNORMAL |
48 |
0.0315 |
| 33 |
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN |
77 |
0.0278 |
| 34 |
ENTEROCOCCAL SEPSIS |
22 |
0.0272 |
| 35 |
GRAFT VERSUS HOST DISEASE IN LIVER |
19 |
0.0265 |
| 36 |
HYPERTONIA NEONATAL |
14 |
0.0262 |
| 37 |
CYSTIC FIBROSIS |
145 |
0.0262 |
| 38 |
LIP PRURITUS |
22 |
0.0257 |
| 39 |
RENAL ISCHAEMIA |
14 |
0.0256 |
| 40 |
PORTAL HYPERTENSION |
79 |
0.0256 |
| 41 |
ACUTE GRAFT VERSUS HOST DISEASE |
117 |
0.0255 |
| 42 |
HEPATORENAL SYNDROME |
43 |
0.0255 |
| 43 |
CHOLANGITIS ACUTE |
19 |
0.0252 |
| 44 |
OESOPHAGEAL ACHALASIA |
16 |
0.0248 |
| 45 |
PANCREATITIS RELAPSING |
20 |
0.0244 |
| 46 |
PSEUDOMONAS TEST POSITIVE |
20 |
0.0244 |
| 47 |
IRON OVERLOAD |
26 |
0.0241 |
| 48 |
LIVER TRANSPLANT |
86 |
0.0236 |
| 49 |
ALLERGIC SINUSITIS |
20 |
0.0233 |
| 50 |
VARICES OESOPHAGEAL |
68 |
0.0225 |
| 51 |
LIVER TRANSPLANT REJECTION |
40 |
0.0222 |
| 52 |
CHOLANGITIS |
138 |
0.0222 |
| 53 |
HEPATIC FIBROSIS |
74 |
0.0215 |
| 54 |
GLOMERULOSCLEROSIS |
13 |
0.0206 |
| 55 |
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE |
29 |
0.0205 |
| 56 |
CHOLANGIOCARCINOMA |
30 |
0.0201 |
| 57 |
GRAFT VERSUS HOST DISEASE |
134 |
0.0186 |
| 58 |
POUCHITIS |
15 |
0.0174 |
| 59 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
37 |
0.0174 |
| 60 |
AXONAL NEUROPATHY |
15 |
0.0172 |
| 61 |
BILE DUCT STONE |
52 |
0.0163 |
| 62 |
ALANINE AMINOTRANSFERASE ABNORMAL |
34 |
0.0161 |
| 63 |
VASCULAR DEVICE INFECTION |
73 |
0.0161 |
| 64 |
CHRONIC GRAFT VERSUS HOST DISEASE |
58 |
0.0160 |
| 65 |
KLEBSIELLA BACTERAEMIA |
15 |
0.0158 |
| 66 |
HEPATIC INFECTION |
20 |
0.0157 |
| 67 |
METASTASES TO SKIN |
16 |
0.0155 |
| 68 |
BILIARY TRACT DISORDER |
21 |
0.0152 |
| 69 |
CYTOMEGALOVIRUS TEST POSITIVE |
26 |
0.0146 |
| 70 |
BILIRUBIN CONJUGATED INCREASED |
34 |
0.0145 |
| 71 |
GRAFT VERSUS HOST DISEASE IN SKIN |
32 |
0.0145 |
| 72 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
37 |
0.0143 |
| 73 |
PLATELET TRANSFUSION |
18 |
0.0140 |
| 74 |
GALLBLADDER ENLARGEMENT |
15 |
0.0139 |
| 75 |
BILIARY OBSTRUCTION |
18 |
0.0139 |
| 76 |
PULMONARY FUNCTION TEST DECREASED |
58 |
0.0132 |
| 77 |
ESCHERICHIA BACTERAEMIA |
30 |
0.0127 |
| 78 |
BLOOD BILIRUBIN ABNORMAL |
16 |
0.0125 |
| 79 |
BLOOD BILIRUBIN INCREASED |
334 |
0.0124 |
| 80 |
EPSTEIN-BARR VIRUS INFECTION REACTIVATION |
16 |
0.0121 |
| 81 |
STEROID DIABETES |
18 |
0.0120 |
| 82 |
EPSTEIN-BARR VIRAEMIA |
13 |
0.0117 |
| 83 |
HEPATIC ENCEPHALOPATHY |
109 |
0.0117 |
| 84 |
MUCOSAL INFLAMMATION |
305 |
0.0116 |
| 85 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
289 |
0.0116 |
| 86 |
EXPOSURE VIA BREAST MILK |
46 |
0.0115 |
| 87 |
OESOPHAGEAL VARICES HAEMORRHAGE |
25 |
0.0115 |
| 88 |
HEPATIC PAIN |
49 |
0.0115 |
| 89 |
HYPERBILIRUBINAEMIA |
117 |
0.0113 |
| 90 |
IMMUNE-MEDIATED HEPATIC DISORDER |
22 |
0.0113 |
| 91 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
45 |
0.0111 |
| 92 |
BONE MARROW TRANSPLANT |
21 |
0.0111 |
| 93 |
HEPATIC CIRRHOSIS |
204 |
0.0108 |
| 94 |
PNEUMONIA CYTOMEGALOVIRAL |
21 |
0.0108 |
| 95 |
ADENOVIRUS INFECTION |
31 |
0.0107 |
| 96 |
CAPILLARY LEAK SYNDROME |
22 |
0.0106 |
| 97 |
CYTOMEGALOVIRUS INFECTION REACTIVATION |
47 |
0.0106 |
| 98 |
GASTROENTERITIS NOROVIRUS |
14 |
0.0105 |
| 99 |
PRE-ECLAMPSIA |
50 |
0.0105 |
| 100 |
LIVER ABSCESS |
34 |
0.0105 |
| 101 |
BLOOD LOSS ANAEMIA |
23 |
0.0101 |
| 102 |
IMMUNE-MEDIATED HEPATITIS |
20 |
0.0098 |
| 103 |
SPUTUM INCREASED |
21 |
0.0097 |
| 104 |
ASCITES |
282 |
0.0096 |
| 105 |
BILIARY DILATATION |
14 |
0.0095 |
| 106 |
AUTOIMMUNE HEPATITIS |
66 |
0.0095 |
| 107 |
ACUTE MYELOID LEUKAEMIA RECURRENT |
20 |
0.0093 |
| 108 |
CHOLESTASIS |
178 |
0.0093 |
| 109 |
HEPATITIS TOXIC |
24 |
0.0092 |
| 110 |
PARAINFLUENZAE VIRUS INFECTION |
14 |
0.0092 |
| 111 |
HEPATIC FAILURE |
273 |
0.0090 |
| 112 |
BILE DUCT OBSTRUCTION |
17 |
0.0090 |
| 113 |
INTRA-ABDOMINAL FLUID COLLECTION |
16 |
0.0089 |
| 114 |
HEPATIC MASS |
17 |
0.0088 |
| 115 |
KIDNEY FIBROSIS |
15 |
0.0086 |
| 116 |
NORMAL NEWBORN |
47 |
0.0086 |
| 117 |
AMMONIA INCREASED |
44 |
0.0086 |
| 118 |
HEPATOSPLENOMEGALY |
22 |
0.0086 |
| 119 |
CHOLESTATIC LIVER INJURY |
19 |
0.0085 |
| 120 |
JAUNDICE CHOLESTATIC |
30 |
0.0085 |
| 121 |
STEM CELL TRANSPLANT |
21 |
0.0084 |
| 122 |
HYPERPHOSPHATAEMIA |
18 |
0.0084 |
| 123 |
PORTAL VEIN THROMBOSIS |
27 |
0.0083 |
| 124 |
HYPOALBUMINAEMIA |
62 |
0.0080 |
| 125 |
HEPATIC NECROSIS |
30 |
0.0080 |
| 126 |
CYSTITIS HAEMORRHAGIC |
32 |
0.0079 |
| 127 |
HUMAN HERPESVIRUS 6 INFECTION |
15 |
0.0079 |
| 128 |
POLYMYOSITIS |
14 |
0.0079 |
| 129 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
223 |
0.0079 |
| 130 |
OCULAR ICTERUS |
34 |
0.0078 |
| 131 |
VARICELLA ZOSTER VIRUS INFECTION |
16 |
0.0077 |
| 132 |
BK VIRUS INFECTION |
26 |
0.0077 |
| 133 |
LUNG TRANSPLANT |
27 |
0.0076 |
| 134 |
PNEUMONIA KLEBSIELLA |
14 |
0.0076 |
| 135 |
PNEUMONIA STAPHYLOCOCCAL |
15 |
0.0076 |
| 136 |
JAUNDICE |
200 |
0.0074 |
| 137 |
FORCED EXPIRATORY VOLUME DECREASED |
21 |
0.0074 |
| 138 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
164 |
0.0074 |
| 139 |
CYTOKINE RELEASE SYNDROME |
146 |
0.0073 |
| 140 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
24 |
0.0073 |
| 141 |
FAECAL CALPROTECTIN INCREASED |
23 |
0.0073 |
| 142 |
HEPATOMEGALY |
71 |
0.0072 |
| 143 |
CYTOMEGALOVIRUS VIRAEMIA |
32 |
0.0072 |
| 144 |
PROCTITIS |
20 |
0.0071 |
| 145 |
STAPHYLOCOCCAL SEPSIS |
35 |
0.0071 |
| 146 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
20 |
0.0071 |
| 147 |
HEPATIC ENZYME ABNORMAL |
35 |
0.0070 |
| 148 |
DEVICE RELATED SEPSIS |
14 |
0.0069 |
| 149 |
TRANSPLANT FAILURE |
17 |
0.0069 |
| 150 |
PSEUDOMONAS INFECTION |
59 |
0.0069 |
| 151 |
HYPERURICAEMIA |
28 |
0.0068 |
| 152 |
PANCREATIC CYST |
13 |
0.0068 |
| 153 |
GASTROINTESTINAL ULCER |
15 |
0.0068 |
| 154 |
PNEUMONIA FUNGAL |
26 |
0.0066 |
| 155 |
BACTERAEMIA |
78 |
0.0066 |
| 156 |
LIVER DISORDER |
286 |
0.0064 |
| 157 |
SPLENOMEGALY |
75 |
0.0064 |
| 158 |
THROMBOTIC MICROANGIOPATHY |
62 |
0.0064 |
| 159 |
ABDOMINAL MASS |
17 |
0.0063 |
| 160 |
DRUG-INDUCED LIVER INJURY |
199 |
0.0063 |
| 161 |
SERUM FERRITIN INCREASED |
33 |
0.0063 |
| 162 |
ASPERGILLUS INFECTION |
41 |
0.0062 |
| 163 |
PHYSICAL DECONDITIONING |
16 |
0.0062 |
| 164 |
ENTEROCOCCAL INFECTION |
30 |
0.0062 |
| 165 |
HEPATIC CYTOLYSIS |
79 |
0.0062 |
| 166 |
STAPHYLOCOCCUS TEST POSITIVE |
13 |
0.0062 |
| 167 |
HEPATIC NEOPLASM MALIGNANT |
13 |
0.0061 |
| 168 |
HAEMATOLOGICAL INFECTION |
15 |
0.0061 |
| 169 |
ASPARTATE AMINOTRANSFERASE INCREASED |
321 |
0.0060 |
| 170 |
CHOLECYSTITIS ACUTE |
34 |
0.0060 |
| 171 |
FEBRILE NEUTROPENIA |
398 |
0.0060 |
| 172 |
IMMUNE-MEDIATED ENTEROCOLITIS |
22 |
0.0060 |
| 173 |
STAPHYLOCOCCAL BACTERAEMIA |
26 |
0.0060 |
| 174 |
SYSTEMIC CANDIDA |
15 |
0.0060 |
| 175 |
PNEUMONIA VIRAL |
19 |
0.0060 |
| 176 |
RENAL TUBULAR ACIDOSIS |
13 |
0.0060 |
| 177 |
BLOOD ALBUMIN DECREASED |
47 |
0.0059 |
| 178 |
TRANSFUSION |
62 |
0.0059 |
| 179 |
FAECES PALE |
13 |
0.0058 |
| 180 |
CYTOMEGALOVIRUS INFECTION |
97 |
0.0058 |
| 181 |
ALANINE AMINOTRANSFERASE INCREASED |
358 |
0.0058 |
| 182 |
CYTOPENIA |
70 |
0.0057 |
| 183 |
BLOOD CULTURE POSITIVE |
17 |
0.0057 |
| 184 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
54 |
0.0057 |
| 185 |
CYTOMEGALOVIRUS COLITIS |
13 |
0.0056 |
| 186 |
ORGANISING PNEUMONIA |
28 |
0.0056 |
| 187 |
STEATORRHOEA |
15 |
0.0056 |
| 188 |
NOCARDIOSIS |
14 |
0.0055 |
| 189 |
RHINOVIRUS INFECTION |
21 |
0.0054 |
| 190 |
IRON DEFICIENCY |
24 |
0.0053 |
| 191 |
HEPATITIS CHOLESTATIC |
32 |
0.0053 |
| 192 |
HEPATIC FUNCTION ABNORMAL |
197 |
0.0053 |
| 193 |
HYPERVOLAEMIA |
26 |
0.0053 |
| 194 |
HEPATOCELLULAR CARCINOMA |
40 |
0.0053 |
| 195 |
DISSEMINATED INTRAVASCULAR COAGULATION |
74 |
0.0053 |
| 196 |
LIVER FUNCTION TEST INCREASED |
111 |
0.0052 |
| 197 |
TOXIC EPIDERMAL NECROLYSIS |
78 |
0.0051 |
| 198 |
HAEMOLYSIS |
39 |
0.0050 |
| 199 |
LOW BIRTH WEIGHT BABY |
40 |
0.0050 |
| 200 |
SEPTIC SHOCK |
218 |
0.0050 |
| 201 |
HYPERAMMONAEMIA |
25 |
0.0050 |
| 202 |
IRON DEFICIENCY ANAEMIA |
46 |
0.0050 |
| 203 |
PREMATURE DELIVERY |
79 |
0.0050 |
| 204 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
29 |
0.0049 |
| 205 |
PULMONARY HAEMORRHAGE |
38 |
0.0049 |
| 206 |
ENTERITIS |
31 |
0.0048 |
| 207 |
PROCTALGIA |
31 |
0.0048 |
| 208 |
PREMATURE BABY |
144 |
0.0048 |
| 209 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
48 |
0.0048 |
| 210 |
B-CELL LYMPHOMA |
16 |
0.0047 |
| 211 |
INTRACRANIAL PRESSURE INCREASED |
26 |
0.0047 |
| 212 |
BRONCHOPULMONARY ASPERGILLOSIS |
36 |
0.0046 |
| 213 |
ESCHERICHIA INFECTION |
38 |
0.0046 |
| 214 |
FIBROSIS |
14 |
0.0045 |
| 215 |
TRANSAMINASES INCREASED |
101 |
0.0045 |
| 216 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
34 |
0.0045 |
| 217 |
ABNORMAL FAECES |
37 |
0.0045 |
| 218 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
79 |
0.0045 |
| 219 |
CARDIAC FAILURE CHRONIC |
19 |
0.0045 |
| 220 |
FOETAL GROWTH RESTRICTION |
27 |
0.0044 |
| 221 |
BLOOD MAGNESIUM DECREASED |
38 |
0.0044 |
| 222 |
CHOLELITHIASIS |
144 |
0.0044 |
| 223 |
NON-SMALL CELL LUNG CANCER |
21 |
0.0044 |
| 224 |
MALNUTRITION |
49 |
0.0044 |
| 225 |
AUTOIMMUNE HAEMOLYTIC ANAEMIA |
15 |
0.0044 |
| 226 |
DRUG LEVEL BELOW THERAPEUTIC |
24 |
0.0043 |
| 227 |
BRONCHIOLITIS |
15 |
0.0043 |
| 228 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
37 |
0.0042 |
| 229 |
DIASTOLIC DYSFUNCTION |
13 |
0.0042 |
| 230 |
HYPOMAGNESAEMIA |
58 |
0.0042 |
| 231 |
HEPATITIS ACUTE |
27 |
0.0042 |
| 232 |
VITAMIN D DEFICIENCY |
40 |
0.0041 |
| 233 |
NEPHROGENIC ANAEMIA |
19 |
0.0041 |
| 234 |
CLOSTRIDIUM DIFFICILE COLITIS |
43 |
0.0041 |
| 235 |
DRUG LEVEL DECREASED |
41 |
0.0040 |
| 236 |
HEPATITIS |
103 |
0.0040 |
| 237 |
SKIN PAPILLOMA |
16 |
0.0040 |
| 238 |
PNEUMONIA BACTERIAL |
36 |
0.0039 |
| 239 |
PANCREATITIS ACUTE |
88 |
0.0039 |
| 240 |
POST-TRAUMATIC STRESS DISORDER |
26 |
0.0039 |
| 241 |
APHTHOUS ULCER |
30 |
0.0039 |
| 242 |
SCLERODERMA |
14 |
0.0038 |
| 243 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
61 |
0.0038 |
| 244 |
BLOOD PHOSPHORUS DECREASED |
14 |
0.0038 |
| 245 |
HYPERNATRAEMIA |
19 |
0.0038 |
| 246 |
PLATELET COUNT ABNORMAL |
23 |
0.0038 |
| 247 |
HYPOPHOSPHATAEMIA |
28 |
0.0038 |
| 248 |
APLASIA PURE RED CELL |
13 |
0.0038 |
| 249 |
ESCHERICHIA URINARY TRACT INFECTION |
16 |
0.0038 |
| 250 |
KLEBSIELLA INFECTION |
19 |
0.0038 |
| 251 |
AZOTAEMIA |
15 |
0.0038 |
| 252 |
HEPATIC ENZYME INCREASED |
256 |
0.0038 |
| 253 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
19 |
0.0037 |
| 254 |
ATELECTASIS |
36 |
0.0037 |
| 255 |
RHINITIS |
30 |
0.0037 |
| 256 |
FAECES SOFT |
27 |
0.0037 |
| 257 |
GASTROINTESTINAL INFLAMMATION |
29 |
0.0037 |
| 258 |
INSURANCE ISSUE |
56 |
0.0037 |
| 259 |
ENTEROCOLITIS |
21 |
0.0036 |
| 260 |
FOOD ALLERGY |
28 |
0.0036 |
| 261 |
ACUTE MYELOID LEUKAEMIA |
56 |
0.0036 |
| 262 |
BACTERIAL INFECTION |
67 |
0.0036 |
| 263 |
PERICARDIAL EFFUSION |
83 |
0.0036 |
| 264 |
COMPRESSION FRACTURE |
19 |
0.0035 |
| 265 |
PANCYTOPENIA |
196 |
0.0035 |
| 266 |
COAGULOPATHY |
58 |
0.0035 |
| 267 |
HEPATOTOXICITY |
77 |
0.0035 |
| 268 |
CARDIAC FAILURE ACUTE |
23 |
0.0034 |
| 269 |
HYPERTRIGLYCERIDAEMIA |
20 |
0.0034 |
| 270 |
SEPSIS |
381 |
0.0034 |
| 271 |
WRONG PRODUCT ADMINISTERED |
23 |
0.0034 |
| 272 |
TRANSPLANT REJECTION |
27 |
0.0034 |
| 273 |
FREQUENT BOWEL MOVEMENTS |
91 |
0.0034 |
| 274 |
COLECTOMY |
19 |
0.0034 |
| 275 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
17 |
0.0034 |
| 276 |
GASTROINTESTINAL INFECTION |
30 |
0.0033 |
| 277 |
PRURITUS |
1283 |
0.0033 |
| 278 |
EPIGASTRIC DISCOMFORT |
13 |
0.0033 |
| 279 |
ACUTE RESPIRATORY FAILURE |
64 |
0.0033 |
| 280 |
SUSPECTED OFF LABEL USE |
15 |
0.0033 |
| 281 |
SHOCK HAEMORRHAGIC |
27 |
0.0033 |
| 282 |
CACHEXIA |
17 |
0.0033 |
| 283 |
NEPHROPATHY TOXIC |
37 |
0.0033 |
| 284 |
DISEASE COMPLICATION |
15 |
0.0033 |
| 285 |
HAEMORRHOIDAL HAEMORRHAGE |
16 |
0.0033 |
| 286 |
CHOLECYSTITIS |
39 |
0.0033 |
| 287 |
BOWEL MOVEMENT IRREGULARITY |
25 |
0.0033 |
| 288 |
CLOSTRIDIUM DIFFICILE INFECTION |
71 |
0.0032 |
| 289 |
SMALL INTESTINAL OBSTRUCTION |
40 |
0.0032 |
| 290 |
PARTIAL SEIZURES |
17 |
0.0032 |
| 291 |
LOCALISED OEDEMA |
15 |
0.0032 |
| 292 |
ENCEPHALOPATHY |
79 |
0.0032 |
| 293 |
ADRENAL INSUFFICIENCY |
39 |
0.0032 |
| 294 |
PLEURAL EFFUSION |
195 |
0.0032 |
| 295 |
YELLOW SKIN |
15 |
0.0032 |
| 296 |
IMMUNOSUPPRESSION |
28 |
0.0032 |
| 297 |
ARTHRITIS BACTERIAL |
13 |
0.0032 |
| 298 |
GASTROENTERITIS |
46 |
0.0031 |
| 299 |
GESTATIONAL DIABETES |
15 |
0.0031 |
| 300 |
RIGHT VENTRICULAR FAILURE |
22 |
0.0031 |
| 301 |
DUODENAL ULCER |
22 |
0.0031 |
| 302 |
NEUTROPHIL COUNT DECREASED |
127 |
0.0031 |
| 303 |
PULMONARY TOXICITY |
22 |
0.0031 |
| 304 |
HYPOXIA |
109 |
0.0031 |
| 305 |
RESPIRATORY FAILURE |
225 |
0.0031 |
| 306 |
HYDRONEPHROSIS |
23 |
0.0031 |
| 307 |
TUMOUR LYSIS SYNDROME |
27 |
0.0031 |
| 308 |
PLATELET COUNT DECREASED |
327 |
0.0031 |
| 309 |
THROMBOCYTOPENIA |
341 |
0.0030 |
| 310 |
SUBARACHNOID HAEMORRHAGE |
31 |
0.0030 |
| 311 |
HYPOTHYROIDISM |
97 |
0.0030 |
| 312 |
GASTROINTESTINAL SOUNDS ABNORMAL |
15 |
0.0030 |
| 313 |
MATERNAL EXPOSURE DURING PREGNANCY |
268 |
0.0030 |
| 314 |
HEPATIC LESION |
13 |
0.0030 |
| 315 |
LYMPHOCYTE COUNT DECREASED |
53 |
0.0030 |
| 316 |
ATRIAL SEPTAL DEFECT |
25 |
0.0030 |
| 317 |
CHROMATURIA |
67 |
0.0030 |
| 318 |
TACHYPNOEA |
40 |
0.0029 |
| 319 |
ACUTE HEPATIC FAILURE |
40 |
0.0029 |
| 320 |
DEVICE RELATED INFECTION |
45 |
0.0029 |
| 321 |
PRODUCT DISTRIBUTION ISSUE |
27 |
0.0029 |
| 322 |
COLITIS ULCERATIVE |
130 |
0.0029 |
| 323 |
AGRANULOCYTOSIS |
54 |
0.0029 |
| 324 |
MULTI-ORGAN FAILURE |
50 |
0.0029 |
| 325 |
HYPERTRANSAMINASAEMIA |
20 |
0.0029 |
| 326 |
MAJOR DEPRESSION |
21 |
0.0029 |
| 327 |
BLOOD UREA INCREASED |
48 |
0.0029 |
| 328 |
INFUSION SITE ERYTHEMA |
24 |
0.0028 |
| 329 |
PREMATURE LABOUR |
16 |
0.0028 |
| 330 |
INTERSTITIAL LUNG DISEASE |
137 |
0.0028 |
| 331 |
HEPATITIS B |
17 |
0.0028 |
| 332 |
BRONCHIECTASIS |
19 |
0.0028 |
| 333 |
ACUTE KIDNEY INJURY |
431 |
0.0028 |
| 334 |
CHOLECYSTECTOMY |
32 |
0.0028 |
| 335 |
GALLBLADDER DISORDER |
50 |
0.0028 |
| 336 |
PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
17 |
0.0028 |
| 337 |
MYOSITIS |
25 |
0.0028 |
| 338 |
HYPOKALAEMIA |
128 |
0.0028 |
| 339 |
CHEILITIS |
15 |
0.0028 |
| 340 |
RENAL CYST |
22 |
0.0028 |
| 341 |
AUTOIMMUNE DISORDER |
27 |
0.0028 |
| 342 |
ENCEPHALITIS |
19 |
0.0027 |
| 343 |
URINE OUTPUT DECREASED |
24 |
0.0027 |
| 344 |
HEPATIC STEATOSIS |
51 |
0.0027 |
| 345 |
LIVER INJURY |
67 |
0.0027 |
| 346 |
LIVER FUNCTION TEST ABNORMAL |
79 |
0.0027 |
| 347 |
FAILURE TO THRIVE |
14 |
0.0027 |
| 348 |
MALABSORPTION |
14 |
0.0027 |
| 349 |
FLUID OVERLOAD |
39 |
0.0027 |
| 350 |
WEIGHT FLUCTUATION |
28 |
0.0027 |
| 351 |
PULMONARY ALVEOLAR HAEMORRHAGE |
15 |
0.0027 |
| 352 |
FLANK PAIN |
25 |
0.0027 |
| 353 |
WHITE BLOOD CELL COUNT ABNORMAL |
17 |
0.0027 |
| 354 |
SCRATCH |
28 |
0.0027 |
| 355 |
FOETAL EXPOSURE DURING PREGNANCY |
213 |
0.0026 |
| 356 |
ABDOMINAL TENDERNESS |
13 |
0.0026 |
| 357 |
RESPIRATORY DISTRESS |
72 |
0.0026 |
| 358 |
STAPHYLOCOCCAL INFECTION |
86 |
0.0026 |
| 359 |
LARGE INTESTINE POLYP |
18 |
0.0026 |
| 360 |
GENERALISED OEDEMA |
32 |
0.0026 |
| 361 |
FAECES DISCOLOURED |
56 |
0.0026 |
| 362 |
HYPERGLYCAEMIA |
94 |
0.0026 |
| 363 |
ILEUS |
32 |
0.0026 |
| 364 |
THERAPY INTERRUPTED |
184 |
0.0026 |
| 365 |
DIARRHOEA HAEMORRHAGIC |
24 |
0.0026 |
| 366 |
HAEMATEMESIS |
65 |
0.0026 |
| 367 |
OESOPHAGITIS |
28 |
0.0026 |
| 368 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
43 |
0.0026 |
| 369 |
CHOLECYSTITIS CHRONIC |
17 |
0.0025 |
| 370 |
PHLEBITIS |
13 |
0.0025 |
| 371 |
GASTRIC ULCER |
48 |
0.0025 |
| 372 |
STOMATITIS |
153 |
0.0025 |
| 373 |
MELAENA |
55 |
0.0025 |
| 374 |
ELECTROLYTE IMBALANCE |
29 |
0.0025 |
| 375 |
THERAPY CESSATION |
128 |
0.0025 |
| 376 |
TYPE 1 DIABETES MELLITUS |
15 |
0.0025 |
| 377 |
MENTAL STATUS CHANGES |
69 |
0.0025 |
| 378 |
HYPOCALCAEMIA |
47 |
0.0025 |
| 379 |
HAEMOPTYSIS |
69 |
0.0025 |
| 380 |
BLOOD POTASSIUM INCREASED |
40 |
0.0025 |
| 381 |
APPENDICITIS |
23 |
0.0025 |
| 382 |
MOUTH HAEMORRHAGE |
18 |
0.0025 |
| 383 |
PYREXIA |
847 |
0.0024 |
| 384 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
25 |
0.0024 |
| 385 |
SKIN ATROPHY |
14 |
0.0024 |
| 386 |
PYELONEPHRITIS |
21 |
0.0024 |
| 387 |
BLOOD TEST ABNORMAL |
34 |
0.0024 |
| 388 |
OLIGURIA |
15 |
0.0024 |
| 389 |
EXPOSURE DURING PREGNANCY |
150 |
0.0024 |
| 390 |
RALES |
14 |
0.0024 |
| 391 |
THERAPY NON-RESPONDER |
108 |
0.0024 |
| 392 |
ABDOMINAL DISTENSION |
250 |
0.0024 |
| 393 |
TRICUSPID VALVE INCOMPETENCE |
19 |
0.0024 |
| 394 |
MITRAL VALVE INCOMPETENCE |
27 |
0.0024 |
| 395 |
COVID-19 PNEUMONIA |
28 |
0.0024 |
| 396 |
POSTOPERATIVE WOUND INFECTION |
16 |
0.0024 |
| 397 |
FULL BLOOD COUNT ABNORMAL |
25 |
0.0024 |
| 398 |
PULMONARY HYPERTENSION |
49 |
0.0024 |
| 399 |
PRODUCT PRESCRIBING ERROR |
56 |
0.0023 |
| 400 |
MATERNAL DRUGS AFFECTING FOETUS |
18 |
0.0023 |
| 401 |
TUBULOINTERSTITIAL NEPHRITIS |
44 |
0.0023 |
| 402 |
PULMONARY ARTERIAL HYPERTENSION |
34 |
0.0023 |
| 403 |
NEUROTOXICITY |
41 |
0.0023 |
| 404 |
HAEMOGLOBIN ABNORMAL |
15 |
0.0023 |
| 405 |
SINUS TACHYCARDIA |
33 |
0.0023 |
| 406 |
CAESAREAN SECTION |
27 |
0.0023 |
| 407 |
TASTE DISORDER |
47 |
0.0023 |
| 408 |
DRUG ERUPTION |
41 |
0.0023 |
| 409 |
INGUINAL HERNIA |
14 |
0.0023 |
| 410 |
DERMATITIS ACNEIFORM |
14 |
0.0023 |
| 411 |
ABDOMINAL PAIN |
533 |
0.0023 |
| 412 |
BLOOD IRON DECREASED |
27 |
0.0023 |
| 413 |
MYOCARDITIS |
26 |
0.0023 |
| 414 |
PURPURA |
20 |
0.0023 |
| 415 |
ANAEMIA |
430 |
0.0023 |
| 416 |
BLOOD URIC ACID INCREASED |
13 |
0.0022 |
| 417 |
END STAGE RENAL DISEASE |
41 |
0.0022 |
| 418 |
RENAL TUBULAR NECROSIS |
22 |
0.0022 |
| 419 |
EPSTEIN-BARR VIRUS INFECTION |
14 |
0.0022 |
| 420 |
NEUTROPENIA |
302 |
0.0022 |
| 421 |
RENAL FAILURE |
294 |
0.0022 |
| 422 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
121 |
0.0022 |
| 423 |
VIRAL INFECTION |
73 |
0.0022 |
| 424 |
PNEUMONIA |
710 |
0.0022 |
| 425 |
PRODUCT ADMINISTRATION ERROR |
44 |
0.0022 |
| 426 |
RESPIRATION ABNORMAL |
15 |
0.0022 |
| 427 |
PROTHROMBIN TIME PROLONGED |
13 |
0.0022 |
| 428 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
16 |
0.0022 |
| 429 |
EOSINOPHIL COUNT INCREASED |
18 |
0.0022 |
| 430 |
HERPES SIMPLEX |
14 |
0.0022 |
| 431 |
PNEUMOTHORAX |
34 |
0.0021 |
| 432 |
INFECTION |
310 |
0.0021 |
| 433 |
POLYP |
14 |
0.0021 |
| 434 |
INABILITY TO AFFORD MEDICATION |
21 |
0.0021 |
| 435 |
PETECHIAE |
22 |
0.0021 |
| 436 |
INTERNAL HAEMORRHAGE |
24 |
0.0021 |
| 437 |
RED BLOOD CELL COUNT DECREASED |
60 |
0.0021 |
| 438 |
INTESTINAL OBSTRUCTION |
79 |
0.0021 |
| 439 |
OFF LABEL USE |
1828 |
0.0021 |
| 440 |
CANDIDA INFECTION |
35 |
0.0021 |
| 441 |
HOSPITALISATION |
318 |
0.0021 |
| 442 |
CEREBRAL HAEMORRHAGE |
74 |
0.0021 |
| 443 |
INFUSION SITE SWELLING |
13 |
0.0021 |
| 444 |
DRUG LEVEL INCREASED |
34 |
0.0021 |
| 445 |
THERAPY PARTIAL RESPONDER |
32 |
0.0020 |
| 446 |
ORAL CANDIDIASIS |
27 |
0.0020 |
| 447 |
NEPHROLITHIASIS |
94 |
0.0020 |
| 448 |
PNEUMONIA ASPIRATION |
51 |
0.0020 |
| 449 |
HOSPICE CARE |
20 |
0.0020 |
| 450 |
RENAL IMPAIRMENT |
170 |
0.0020 |
| 451 |
LARGE INTESTINE PERFORATION |
14 |
0.0020 |
| 452 |
ORAL PAIN |
45 |
0.0020 |
| 453 |
COLITIS |
76 |
0.0020 |
| 454 |
LABORATORY TEST ABNORMAL |
59 |
0.0020 |
| 455 |
PROTEINURIA |
38 |
0.0020 |
| 456 |
GASTROENTERITIS VIRAL |
36 |
0.0020 |
| 457 |
METASTASES TO LUNG |
23 |
0.0020 |
| 458 |
PAPULE |
14 |
0.0020 |
| 459 |
OEDEMA PERIPHERAL |
242 |
0.0020 |
| 460 |
SUPRAVENTRICULAR TACHYCARDIA |
19 |
0.0020 |
| 461 |
SKIN HYPERPIGMENTATION |
17 |
0.0020 |
| 462 |
URINARY RETENTION |
66 |
0.0020 |
| 463 |
EATING DISORDER |
42 |
0.0020 |
| 464 |
PULMONARY CONGESTION |
26 |
0.0020 |
| 465 |
ACIDOSIS |
15 |
0.0020 |
| 466 |
HAEMATOCHEZIA |
108 |
0.0020 |
| 467 |
FUNGAL INFECTION |
65 |
0.0019 |
| 468 |
BLOOD CREATININE INCREASED |
127 |
0.0019 |
| 469 |
THERAPY CHANGE |
19 |
0.0019 |
| 470 |
ERYTHEMA MULTIFORME |
18 |
0.0019 |
| 471 |
PELVIC FRACTURE |
15 |
0.0019 |
| 472 |
EPISTAXIS |
143 |
0.0019 |
| 473 |
BODY TEMPERATURE INCREASED |
39 |
0.0019 |
| 474 |
PNEUMONITIS |
52 |
0.0019 |
| 475 |
HAEMOLYTIC ANAEMIA |
17 |
0.0019 |
| 476 |
PRURITUS GENERALISED |
41 |
0.0019 |
| 477 |
DECREASED APPETITE |
440 |
0.0019 |
| 478 |
ANAL INCONTINENCE |
17 |
0.0019 |
| 479 |
DYSPNOEA EXERTIONAL |
71 |
0.0019 |
| 480 |
METASTASES TO LIVER |
33 |
0.0019 |
| 481 |
HAEMATOCRIT DECREASED |
37 |
0.0019 |
| 482 |
PRODUCTIVE COUGH |
89 |
0.0019 |
| 483 |
HYPERCALCAEMIA |
23 |
0.0019 |
| 484 |
INTERNATIONAL NORMALISED RATIO INCREASED |
53 |
0.0019 |
| 485 |
PEMPHIGOID |
14 |
0.0019 |
| 486 |
GASTROINTESTINAL HAEMORRHAGE |
155 |
0.0019 |
| 487 |
SCAB |
21 |
0.0018 |
| 488 |
PLATELET COUNT INCREASED |
24 |
0.0018 |
| 489 |
POOR VENOUS ACCESS |
19 |
0.0018 |
| 490 |
HYPONATRAEMIA |
103 |
0.0018 |
| 491 |
LIPASE INCREASED |
14 |
0.0018 |
| 492 |
POST PROCEDURAL COMPLICATION |
35 |
0.0018 |
| 493 |
BRAIN OEDEMA |
23 |
0.0018 |
| 494 |
NOCTURIA |
22 |
0.0018 |
| 495 |
MUSCULOSKELETAL CHEST PAIN |
28 |
0.0018 |
| 496 |
FLUID RETENTION |
92 |
0.0018 |
| 497 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
20 |
0.0018 |
| 498 |
MYELOSUPPRESSION |
65 |
0.0018 |
| 499 |
HYPOPHAGIA |
46 |
0.0018 |
| 500 |
LIVE BIRTH |
15 |
0.0018 |
| 501 |
HAEMODIALYSIS |
15 |
0.0018 |
| 502 |
INFUSION SITE PAIN |
23 |
0.0018 |
| 503 |
WHITE BLOOD CELL COUNT DECREASED |
193 |
0.0018 |
| 504 |
ORTHOSTATIC HYPOTENSION |
31 |
0.0018 |
| 505 |
OSTEOPENIA |
27 |
0.0018 |
| 506 |
CONSTIPATION |
387 |
0.0018 |
| 507 |
OEDEMA |
96 |
0.0018 |
| 508 |
LIP DRY |
16 |
0.0018 |
| 509 |
STEVENS-JOHNSON SYNDROME |
39 |
0.0018 |
| 510 |
ABDOMINAL PAIN UPPER |
361 |
0.0018 |
| 511 |
DIARRHOEA |
1130 |
0.0017 |
| 512 |
SUBDURAL HAEMATOMA |
25 |
0.0017 |
| 513 |
ANURIA |
15 |
0.0017 |
| 514 |
HYPERKALAEMIA |
61 |
0.0017 |
| 515 |
HEPATITIS C |
21 |
0.0017 |
| 516 |
FULL BLOOD COUNT DECREASED |
35 |
0.0017 |
| 517 |
MYOPATHY |
15 |
0.0017 |
| 518 |
DISEASE PROGRESSION |
205 |
0.0017 |
| 519 |
INTERVERTEBRAL DISC DEGENERATION |
16 |
0.0017 |
| 520 |
PULMONARY OEDEMA |
77 |
0.0017 |
| 521 |
POST PROCEDURAL HAEMORRHAGE |
20 |
0.0017 |
| 522 |
GLOMERULAR FILTRATION RATE DECREASED |
21 |
0.0017 |
| 523 |
RASH MACULO-PAPULAR |
38 |
0.0017 |
| 524 |
ULCER |
27 |
0.0017 |
| 525 |
SEASONAL ALLERGY |
24 |
0.0017 |
| 526 |
FLATULENCE |
96 |
0.0017 |
| 527 |
IMPAIRED GASTRIC EMPTYING |
23 |
0.0017 |
| 528 |
INFLUENZA |
188 |
0.0017 |
| 529 |
LUNG INFECTION |
26 |
0.0017 |
| 530 |
CELLULITIS |
84 |
0.0017 |
| 531 |
HAEMOGLOBIN DECREASED |
171 |
0.0017 |
| 532 |
DEHYDRATION |
222 |
0.0017 |
| 533 |
DRUG INTERACTION |
264 |
0.0017 |
| 534 |
MYELODYSPLASTIC SYNDROME |
24 |
0.0017 |
| 535 |
MULTIPLE ALLERGIES |
13 |
0.0017 |
| 536 |
MUSCLE ATROPHY |
21 |
0.0017 |
| 537 |
SKIN LACERATION |
18 |
0.0017 |
| 538 |
GASTRIC HAEMORRHAGE |
19 |
0.0016 |
| 539 |
SKIN LESION |
45 |
0.0016 |
| 540 |
ORAL HERPES |
32 |
0.0016 |
| 541 |
BLOOD POTASSIUM DECREASED |
49 |
0.0016 |
| 542 |
ATRIAL FLUTTER |
13 |
0.0016 |
| 543 |
RENAL FAILURE ACUTE |
69 |
0.0016 |
| 544 |
EAR INFECTION |
43 |
0.0016 |
| 545 |
INCONTINENCE |
17 |
0.0016 |
| 546 |
BONE PAIN |
94 |
0.0016 |
| 547 |
BLOOD CALCIUM INCREASED |
14 |
0.0016 |
| 548 |
PHOTOPHOBIA |
30 |
0.0016 |
| 549 |
METABOLIC ACIDOSIS |
51 |
0.0016 |
| 550 |
LEUKAEMIA |
15 |
0.0016 |
| 551 |
PANCREATITIS |
84 |
0.0016 |
| 552 |
POLYURIA |
13 |
0.0016 |
| 553 |
GASTROINTESTINAL DISORDER |
142 |
0.0016 |
| 554 |
LUNG INFILTRATION |
14 |
0.0016 |
| 555 |
HICCUPS |
13 |
0.0016 |
| 556 |
RHABDOMYOLYSIS |
66 |
0.0016 |
| 557 |
FEEDING DISORDER |
32 |
0.0016 |
| 558 |
BONE MARROW FAILURE |
32 |
0.0016 |
| 559 |
SPINAL COMPRESSION FRACTURE |
13 |
0.0016 |
| 560 |
COVID-19 |
275 |
0.0016 |
| 561 |
MOUTH ULCERATION |
33 |
0.0016 |
| 562 |
EMBOLISM |
13 |
0.0016 |
| 563 |
SINUS DISORDER |
31 |
0.0016 |
| 564 |
SHOCK |
36 |
0.0016 |
| 565 |
NEURALGIA |
38 |
0.0016 |
| 566 |
WEIGHT DECREASED |
436 |
0.0016 |
| 567 |
ASPIRATION |
17 |
0.0016 |
| 568 |
OXYGEN SATURATION DECREASED |
87 |
0.0015 |
| 569 |
VASCULITIS |
18 |
0.0015 |
| 570 |
CARDIOMEGALY |
19 |
0.0015 |
| 571 |
C-REACTIVE PROTEIN INCREASED |
56 |
0.0015 |
| 572 |
BLOOD SODIUM DECREASED |
29 |
0.0015 |
| 573 |
PRODUCT AVAILABILITY ISSUE |
35 |
0.0015 |
| 574 |
DENTAL CARIES |
17 |
0.0015 |
| 575 |
RECTAL HAEMORRHAGE |
66 |
0.0015 |
| 576 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
44 |
0.0015 |
| 577 |
RENAL DISORDER |
71 |
0.0015 |
| 578 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
73 |
0.0015 |
| 579 |
HAEMATURIA |
52 |
0.0015 |
| 580 |
INTENTIONAL PRODUCT USE ISSUE |
133 |
0.0015 |
| 581 |
SECRETION DISCHARGE |
19 |
0.0015 |
| 582 |
BLOOD COUNT ABNORMAL |
23 |
0.0015 |
| 583 |
CARDIAC FAILURE |
121 |
0.0015 |
| 584 |
HYPOTENSION |
302 |
0.0015 |
| 585 |
CARDIAC MURMUR |
13 |
0.0015 |
| 586 |
HERNIA |
29 |
0.0015 |
| 587 |
MIDDLE INSOMNIA |
28 |
0.0015 |
| 588 |
PREGNANCY |
30 |
0.0015 |
| 589 |
LYMPHADENOPATHY |
53 |
0.0015 |
| 590 |
COUGH |
419 |
0.0015 |
| 591 |
DRY EYE |
74 |
0.0015 |
| 592 |
GENERAL PHYSICAL HEALTH DETERIORATION |
171 |
0.0015 |
| 593 |
PULMONARY MASS |
22 |
0.0015 |
| 594 |
BLOOD URINE PRESENT |
28 |
0.0015 |
| 595 |
PERIPHERAL COLDNESS |
20 |
0.0015 |
| 596 |
WEIGHT INCREASED |
325 |
0.0014 |
| 597 |
LUNG DISORDER |
71 |
0.0014 |
| 598 |
OBSTRUCTIVE AIRWAYS DISORDER |
16 |
0.0014 |
| 599 |
RESPIRATORY DISORDER |
43 |
0.0014 |
| 600 |
URINARY TRACT INFECTION |
245 |
0.0014 |
| 601 |
LUPUS-LIKE SYNDROME |
13 |
0.0014 |
| 602 |
HAEMATOMA |
37 |
0.0014 |
| 603 |
FISTULA |
16 |
0.0014 |
| 604 |
BODY TEMPERATURE DECREASED |
14 |
0.0014 |
| 605 |
DRUG WITHDRAWAL SYNDROME NEONATAL |
21 |
0.0014 |
| 606 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
56 |
0.0014 |
| 607 |
BLOOD TRIGLYCERIDES INCREASED |
25 |
0.0014 |
| 608 |
INCREASED TENDENCY TO BRUISE |
13 |
0.0014 |
| 609 |
IMMUNODEFICIENCY |
21 |
0.0014 |
| 610 |
BLOOD GLUCOSE ABNORMAL |
26 |
0.0014 |
| 611 |
FATIGUE |
1095 |
0.0014 |
| 612 |
VOMITING |
660 |
0.0014 |
| 613 |
GINGIVAL BLEEDING |
19 |
0.0014 |
| 614 |
PHARYNGITIS STREPTOCOCCAL |
15 |
0.0014 |
| 615 |
BLOOD PRESSURE SYSTOLIC INCREASED |
27 |
0.0014 |
| 616 |
DELIRIUM |
48 |
0.0014 |
| 617 |
SQUAMOUS CELL CARCINOMA |
13 |
0.0014 |
| 618 |
OBESITY |
22 |
0.0014 |
| 619 |
DRY MOUTH |
112 |
0.0014 |
| 620 |
DIVERTICULITIS |
38 |
0.0014 |
| 621 |
INITIAL INSOMNIA |
14 |
0.0014 |
| 622 |
INCREASED APPETITE |
26 |
0.0014 |
| 623 |
CHILLS |
159 |
0.0014 |
| 624 |
PRODUCT DOSE OMISSION |
88 |
0.0013 |
| 625 |
CONJUNCTIVITIS |
25 |
0.0013 |
| 626 |
PRODUCT DOSE OMISSION ISSUE |
396 |
0.0013 |
| 627 |
ERUCTATION |
26 |
0.0013 |
| 628 |
BRAIN FOG |
21 |
0.0013 |
| 629 |
OROPHARYNGEAL PAIN |
124 |
0.0013 |
| 630 |
BLOOD PRESSURE DECREASED |
89 |
0.0013 |
| 631 |
HYPERLIPIDAEMIA |
16 |
0.0013 |
| 632 |
ASTHENIA |
502 |
0.0013 |
| 633 |
BLOOD CALCIUM DECREASED |
15 |
0.0013 |
| 634 |
HAEMORRHOIDS |
26 |
0.0013 |
| 635 |
CONDITION AGGRAVATED |
405 |
0.0013 |
| 636 |
GASTRITIS |
35 |
0.0013 |
| 637 |
INFUSION RELATED REACTION |
88 |
0.0013 |
| 638 |
REBOUND EFFECT |
15 |
0.0013 |
| 639 |
HERPES ZOSTER |
76 |
0.0013 |
| 640 |
RHINORRHOEA |
85 |
0.0013 |
| 641 |
LIGAMENT SPRAIN |
13 |
0.0013 |
| 642 |
EOSINOPHILIA |
23 |
0.0013 |
| 643 |
HYPERTHYROIDISM |
19 |
0.0013 |
| 644 |
RASH PRURITIC |
71 |
0.0013 |
| 645 |
RESPIRATORY TRACT INFECTION |
34 |
0.0013 |
| 646 |
WHITE BLOOD CELL COUNT INCREASED |
50 |
0.0013 |
| 647 |
UPPER RESPIRATORY TRACT INFECTION |
60 |
0.0013 |
| 648 |
GASTROOESOPHAGEAL REFLUX DISEASE |
104 |
0.0013 |
| 649 |
BLOOD PRESSURE FLUCTUATION |
31 |
0.0013 |
| 650 |
IMMUNE SYSTEM DISORDER |
17 |
0.0013 |
| 651 |
CONFUSIONAL STATE |
208 |
0.0013 |
| 652 |
LETHARGY |
74 |
0.0013 |
| 653 |
CARDIOMYOPATHY |
19 |
0.0013 |
| 654 |
ANAPHYLACTIC REACTION |
71 |
0.0013 |
| 655 |
DRUG RESISTANCE |
33 |
0.0013 |
| 656 |
ABDOMINAL DISCOMFORT |
215 |
0.0013 |
| 657 |
HYPERTENSION |
271 |
0.0013 |
| 658 |
HALLUCINATION, VISUAL |
27 |
0.0013 |
| 659 |
SLEEP DISORDER |
90 |
0.0013 |
| 660 |
NEUROPATHY PERIPHERAL |
121 |
0.0013 |
| 661 |
CYANOSIS |
20 |
0.0013 |
| 662 |
PRODUCT DOSE OMISSION IN ERROR |
36 |
0.0013 |
| 663 |
NAUSEA |
1004 |
0.0013 |
| 664 |
ATRIAL FIBRILLATION |
123 |
0.0013 |
| 665 |
DISORIENTATION |
50 |
0.0013 |
| 666 |
BLOOD PRESSURE INCREASED |
191 |
0.0012 |
| 667 |
FACE OEDEMA |
21 |
0.0012 |
| 668 |
HEAD DISCOMFORT |
22 |
0.0012 |
| 669 |
ECZEMA |
65 |
0.0012 |
| 670 |
OSTEOPOROSIS |
51 |
0.0012 |
| 671 |
HIATUS HERNIA |
16 |
0.0012 |
| 672 |
INTENTIONAL DOSE OMISSION |
35 |
0.0012 |
| 673 |
CYSTITIS |
39 |
0.0012 |
| 674 |
TREATMENT NONCOMPLIANCE |
67 |
0.0012 |
| 675 |
DYSPEPSIA |
120 |
0.0012 |
| 676 |
TACHYCARDIA |
108 |
0.0012 |
| 677 |
HIP FRACTURE |
39 |
0.0012 |
| 678 |
CARDIAC ARREST |
100 |
0.0012 |
| 679 |
TOOTH EXTRACTION |
15 |
0.0012 |
| 680 |
UPPER LIMB FRACTURE |
24 |
0.0012 |
| 681 |
HAEMORRHAGE INTRACRANIAL |
18 |
0.0012 |
| 682 |
ILLNESS |
124 |
0.0012 |
| 683 |
PRESCRIBED UNDERDOSE |
24 |
0.0012 |
| 684 |
PRODUCT USE IN UNAPPROVED INDICATION |
298 |
0.0012 |
| 685 |
ALTERED STATE OF CONSCIOUSNESS |
26 |
0.0012 |
| 686 |
DISEASE RECURRENCE |
57 |
0.0012 |
| 687 |
DIALYSIS |
17 |
0.0012 |
| 688 |
SPINAL FRACTURE |
24 |
0.0012 |
| 689 |
PRESYNCOPE |
29 |
0.0012 |
| 690 |
PULMONARY THROMBOSIS |
13 |
0.0012 |
| 691 |
PRODUCT USE ISSUE |
224 |
0.0012 |
| 692 |
CONTUSION |
114 |
0.0012 |
| 693 |
HYPOGLYCAEMIA |
57 |
0.0012 |
| 694 |
CHRONIC KIDNEY DISEASE |
89 |
0.0012 |
| 695 |
ANAPHYLACTIC SHOCK |
30 |
0.0012 |
| 696 |
PERIPHERAL SWELLING |
179 |
0.0012 |
| 697 |
HAEMORRHAGE |
121 |
0.0012 |
| 698 |
SKIN DISCOLOURATION |
53 |
0.0012 |
| 699 |
RASH ERYTHEMATOUS |
55 |
0.0011 |
| 700 |
ABDOMINAL PAIN LOWER |
29 |
0.0011 |
| 701 |
CEREBRAL INFARCTION |
28 |
0.0011 |
| 702 |
DIABETES MELLITUS |
87 |
0.0011 |
| 703 |
DEVICE OCCLUSION |
16 |
0.0011 |
| 704 |
PHARYNGITIS |
14 |
0.0011 |
| 705 |
HEPATOCELLULAR INJURY |
16 |
0.0011 |
| 706 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
29 |
0.0011 |
| 707 |
CHEST DISCOMFORT |
115 |
0.0011 |
| 708 |
CARDIOGENIC SHOCK |
16 |
0.0011 |
| 709 |
NASOPHARYNGITIS |
205 |
0.0011 |
| 710 |
DYSPHAGIA |
105 |
0.0011 |
| 711 |
LEUKOCYTOSIS |
20 |
0.0011 |
| 712 |
POLLAKIURIA |
46 |
0.0011 |
| 713 |
COMPLICATION ASSOCIATED WITH DEVICE |
16 |
0.0011 |
| 714 |
EJECTION FRACTION DECREASED |
17 |
0.0011 |
| 715 |
BASAL CELL CARCINOMA |
17 |
0.0011 |
| 716 |
INSOMNIA |
290 |
0.0011 |
| 717 |
SKIN ULCER |
28 |
0.0011 |
| 718 |
EAR PAIN |
21 |
0.0011 |
| 719 |
DRUG EFFECT LESS THAN EXPECTED |
16 |
0.0011 |
| 720 |
COLD SWEAT |
19 |
0.0011 |
| 721 |
APHONIA |
15 |
0.0011 |
| 722 |
BRADYCARDIA |
57 |
0.0011 |
| 723 |
MASS |
15 |
0.0011 |
| 724 |
BLOOD CHOLESTEROL INCREASED |
50 |
0.0011 |
| 725 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
25 |
0.0011 |
| 726 |
RASH |
467 |
0.0011 |
| 727 |
CARPAL TUNNEL SYNDROME |
15 |
0.0011 |
| 728 |
THROMBOSIS |
86 |
0.0011 |
| 729 |
NO THERAPEUTIC RESPONSE |
13 |
0.0011 |
| 730 |
CHEST PAIN |
197 |
0.0011 |
| 731 |
PERITONITIS |
22 |
0.0011 |
| 732 |
LYMPHOPENIA |
15 |
0.0011 |
| 733 |
TOXICITY TO VARIOUS AGENTS |
178 |
0.0011 |
| 734 |
SOMNOLENCE |
211 |
0.0010 |
| 735 |
HYPERSOMNIA |
30 |
0.0010 |
| 736 |
JOINT RANGE OF MOTION DECREASED |
14 |
0.0010 |
| 737 |
ARTHRALGIA |
433 |
0.0010 |
| 738 |
ANGIOEDEMA |
46 |
0.0010 |
| 739 |
OSTEOARTHRITIS |
44 |
0.0010 |
| 740 |
MALIGNANT NEOPLASM PROGRESSION |
106 |
0.0010 |
| 741 |
MYALGIA |
175 |
0.0010 |
| 742 |
HEART RATE DECREASED |
36 |
0.0010 |
| 743 |
PAIN IN JAW |
29 |
0.0010 |
| 744 |
LACTIC ACIDOSIS |
33 |
0.0010 |
| 745 |
PRODUCT USE COMPLAINT |
16 |
0.0010 |
| 746 |
BRONCHITIS |
75 |
0.0010 |
| 747 |
HEART RATE INCREASED |
100 |
0.0010 |
| 748 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
13 |
0.0010 |
| 749 |
NEOPLASM PROGRESSION |
35 |
0.0010 |
| 750 |
DYSPNOEA |
568 |
0.0010 |
| 751 |
GOUT |
18 |
0.0010 |
| 752 |
CIRCULATORY COLLAPSE |
17 |
0.0010 |
| 753 |
SINUSITIS |
102 |
0.0010 |
| 754 |
SCAR |
17 |
0.0010 |
| 755 |
LOCALISED INFECTION |
24 |
0.0010 |
| 756 |
PALLOR |
27 |
0.0010 |
| 757 |
DYSPHONIA |
58 |
0.0010 |
| 758 |
HEADACHE |
611 |
0.0010 |
| 759 |
DIZZINESS |
485 |
0.0010 |
| 760 |
SURGERY |
57 |
0.0010 |
| 761 |
FALL |
323 |
0.0010 |
| 762 |
INFLAMMATION |
50 |
0.0010 |
| 763 |
BACK PAIN |
224 |
0.0010 |
| 764 |
DRUG INTOLERANCE |
93 |
0.0010 |
| 765 |
SINUS CONGESTION |
13 |
0.0010 |
| 766 |
BLOOD PRESSURE ABNORMAL |
19 |
0.0010 |
| 767 |
DYSURIA |
35 |
0.0009 |
| 768 |
MUSCULAR WEAKNESS |
108 |
0.0009 |
| 769 |
CENTRAL NERVOUS SYSTEM LESION |
13 |
0.0009 |
| 770 |
TREMOR |
157 |
0.0009 |
| 771 |
RESPIRATORY TRACT CONGESTION |
15 |
0.0009 |
| 772 |
MALAISE |
414 |
0.0009 |
| 773 |
LOWER LIMB FRACTURE |
18 |
0.0009 |
| 774 |
BONE DISORDER |
17 |
0.0009 |
| 775 |
DYSARTHRIA |
35 |
0.0009 |
| 776 |
POOR QUALITY SLEEP |
20 |
0.0009 |
| 777 |
ABORTION SPONTANEOUS |
37 |
0.0009 |
| 778 |
CARDIAC FAILURE CONGESTIVE |
74 |
0.0009 |
| 779 |
SKIN FISSURES |
18 |
0.0009 |
| 780 |
TYPE 2 DIABETES MELLITUS |
31 |
0.0009 |
| 781 |
LIMB INJURY |
25 |
0.0009 |
| 782 |
LEUKOPENIA |
46 |
0.0009 |
| 783 |
NASAL CONGESTION |
54 |
0.0009 |
| 784 |
KIDNEY INFECTION |
18 |
0.0009 |
| 785 |
PULMONARY EMBOLISM |
87 |
0.0009 |
| 786 |
SEIZURE |
105 |
0.0009 |
| 787 |
VENTRICULAR TACHYCARDIA |
15 |
0.0009 |
| 788 |
RESPIRATORY ARREST |
25 |
0.0009 |
| 789 |
LYMPHOMA |
14 |
0.0009 |
| 790 |
FEMUR FRACTURE |
28 |
0.0009 |
| 791 |
NIGHT SWEATS |
29 |
0.0009 |
| 792 |
SYNCOPE |
90 |
0.0009 |
| 793 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
161 |
0.0009 |
| 794 |
DYSSTASIA |
26 |
0.0009 |
| 795 |
DEPRESSION |
202 |
0.0009 |
| 796 |
ARRHYTHMIA |
42 |
0.0009 |
| 797 |
EYE PAIN |
50 |
0.0009 |
| 798 |
HEMIPARESIS |
15 |
0.0009 |
| 799 |
DEEP VEIN THROMBOSIS |
57 |
0.0009 |
| 800 |
RENAL INJURY |
26 |
0.0009 |
| 801 |
PRODUCT PRESCRIBING ISSUE |
19 |
0.0009 |
| 802 |
SKIN DISORDER |
29 |
0.0009 |
| 803 |
ARTHRITIS |
68 |
0.0009 |
| 804 |
ELECTROCARDIOGRAM QT PROLONGED |
31 |
0.0009 |
| 805 |
DEMENTIA |
24 |
0.0009 |
| 806 |
ADVERSE DRUG REACTION |
77 |
0.0009 |
| 807 |
HEAD INJURY |
27 |
0.0009 |
| 808 |
METASTASES TO BONE |
14 |
0.0009 |
| 809 |
MANIA |
14 |
0.0009 |
| 810 |
ANXIETY |
242 |
0.0008 |
| 811 |
RASH PAPULAR |
19 |
0.0008 |
| 812 |
DIPLOPIA |
22 |
0.0008 |
| 813 |
RETCHING |
18 |
0.0008 |
| 814 |
FOOT FRACTURE |
16 |
0.0008 |
| 815 |
PSYCHOMOTOR HYPERACTIVITY |
14 |
0.0008 |
| 816 |
SPEECH DISORDER |
44 |
0.0008 |
| 817 |
IRRITABLE BOWEL SYNDROME |
18 |
0.0008 |
| 818 |
BALANCE DISORDER |
72 |
0.0008 |
| 819 |
HEPATIC CANCER |
20 |
0.0008 |
| 820 |
PROCEDURAL PAIN |
23 |
0.0008 |
| 821 |
OSTEOMYELITIS |
15 |
0.0008 |
| 822 |
RIB FRACTURE |
17 |
0.0008 |
| 823 |
RESTLESSNESS |
30 |
0.0008 |
| 824 |
DEATH |
706 |
0.0008 |
| 825 |
EPILEPSY |
25 |
0.0008 |
| 826 |
ABSCESS |
13 |
0.0008 |
| 827 |
ASTHMA |
92 |
0.0008 |
| 828 |
ALOPECIA |
159 |
0.0008 |
| 829 |
GAIT INABILITY |
27 |
0.0008 |
| 830 |
LOSS OF CONSCIOUSNESS |
103 |
0.0008 |
| 831 |
NERVOUS SYSTEM DISORDER |
25 |
0.0008 |
| 832 |
PAIN IN EXTREMITY |
235 |
0.0008 |
| 833 |
APHASIA |
24 |
0.0008 |
| 834 |
PALPITATIONS |
93 |
0.0008 |
| 835 |
ILL-DEFINED DISORDER |
48 |
0.0008 |
| 836 |
SKIN CANCER |
17 |
0.0008 |
| 837 |
CATARACT |
47 |
0.0008 |
| 838 |
GENERALISED TONIC-CLONIC SEIZURE |
13 |
0.0008 |
| 839 |
PERICARDITIS |
13 |
0.0008 |
| 840 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
55 |
0.0008 |
| 841 |
CRYING |
28 |
0.0008 |
| 842 |
DERMATITIS |
16 |
0.0008 |
| 843 |
AGEUSIA |
19 |
0.0008 |
| 844 |
MUSCLE SPASMS |
139 |
0.0008 |
| 845 |
DRY SKIN |
101 |
0.0008 |
| 846 |
MUSCULOSKELETAL DISCOMFORT |
13 |
0.0008 |
| 847 |
AMNESIA |
49 |
0.0008 |
| 848 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
19 |
0.0008 |
| 849 |
FLUSHING |
76 |
0.0007 |
| 850 |
EYE PRURITUS |
25 |
0.0007 |
| 851 |
MEMORY IMPAIRMENT |
102 |
0.0007 |
| 852 |
MUSCLE TWITCHING |
17 |
0.0007 |
| 853 |
TREATMENT FAILURE |
61 |
0.0007 |
| 854 |
THROAT IRRITATION |
33 |
0.0007 |
| 855 |
DIABETES MELLITUS INADEQUATE CONTROL |
13 |
0.0007 |
| 856 |
SLEEP APNOEA SYNDROME |
14 |
0.0007 |
| 857 |
BLOOD GLUCOSE DECREASED |
35 |
0.0007 |
| 858 |
DRUG INEFFECTIVE |
959 |
0.0007 |
| 859 |
LOWER RESPIRATORY TRACT INFECTION |
33 |
0.0007 |
| 860 |
VERTIGO |
44 |
0.0007 |
| 861 |
DEPRESSED MOOD |
38 |
0.0007 |
| 862 |
WOUND |
20 |
0.0007 |
| 863 |
PAIN |
439 |
0.0007 |
| 864 |
FEELING ABNORMAL |
171 |
0.0007 |
| 865 |
WHEEZING |
42 |
0.0007 |
| 866 |
HEART RATE IRREGULAR |
16 |
0.0007 |
| 867 |
AGITATION |
52 |
0.0007 |
| 868 |
GAIT DISTURBANCE |
135 |
0.0007 |
| 869 |
THROAT TIGHTNESS |
19 |
0.0007 |
| 870 |
GASTRIC DISORDER |
24 |
0.0007 |
| 871 |
URTICARIA |
117 |
0.0007 |
| 872 |
JOINT STIFFNESS |
18 |
0.0007 |
| 873 |
SWELLING |
64 |
0.0007 |
| 874 |
DRUG DOSE OMISSION |
113 |
0.0007 |
| 875 |
FEELING COLD |
19 |
0.0007 |
| 876 |
FEELING JITTERY |
13 |
0.0007 |
| 877 |
ERYTHEMA |
140 |
0.0007 |
| 878 |
HYPERSENSITIVITY |
126 |
0.0007 |
| 879 |
ACUTE MYOCARDIAL INFARCTION |
20 |
0.0007 |
| 880 |
EYE IRRITATION |
39 |
0.0007 |
| 881 |
UNDERDOSE |
49 |
0.0007 |
| 882 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
35 |
0.0007 |
| 883 |
CARDIO-RESPIRATORY ARREST |
28 |
0.0007 |
| 884 |
FEELING HOT |
41 |
0.0007 |
| 885 |
MENTAL DISORDER |
29 |
0.0007 |
| 886 |
MUSCULOSKELETAL STIFFNESS |
58 |
0.0007 |
| 887 |
UNEVALUABLE EVENT |
50 |
0.0007 |
| 888 |
MENTAL IMPAIRMENT |
16 |
0.0007 |
| 889 |
NEOPLASM MALIGNANT |
44 |
0.0007 |
| 890 |
BLISTER |
37 |
0.0007 |
| 891 |
RASH MACULAR |
23 |
0.0007 |
| 892 |
INJECTION SITE PRURITUS |
44 |
0.0007 |
| 893 |
ACCIDENTAL OVERDOSE |
24 |
0.0007 |
| 894 |
JOINT INJURY |
14 |
0.0007 |
| 895 |
JOINT SWELLING |
79 |
0.0007 |
| 896 |
TINNITUS |
30 |
0.0007 |
| 897 |
COMA |
31 |
0.0007 |
| 898 |
ANGER |
22 |
0.0006 |
| 899 |
DEAFNESS |
17 |
0.0006 |
| 900 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
23 |
0.0006 |
| 901 |
CONVULSION |
37 |
0.0006 |
| 902 |
SWELLING FACE |
42 |
0.0006 |
| 903 |
NECK PAIN |
36 |
0.0006 |
| 904 |
THERAPEUTIC RESPONSE DECREASED |
39 |
0.0006 |
| 905 |
URINARY INCONTINENCE |
19 |
0.0006 |
| 906 |
DISCOMFORT |
39 |
0.0006 |
| 907 |
ABNORMAL BEHAVIOUR |
25 |
0.0006 |
| 908 |
VISUAL IMPAIRMENT |
78 |
0.0006 |
| 909 |
MOOD SWINGS |
20 |
0.0006 |
| 910 |
HALLUCINATION |
47 |
0.0006 |
| 911 |
MOOD ALTERED |
17 |
0.0006 |
| 912 |
INFLUENZA LIKE ILLNESS |
51 |
0.0006 |
| 913 |
FIBROMYALGIA |
15 |
0.0006 |
| 914 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
18 |
0.0006 |
| 915 |
THERAPEUTIC RESPONSE SHORTENED |
20 |
0.0006 |
| 916 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
27 |
0.0006 |
| 917 |
MOBILITY DECREASED |
43 |
0.0006 |
| 918 |
LACRIMATION INCREASED |
18 |
0.0006 |
| 919 |
INTERVERTEBRAL DISC PROTRUSION |
13 |
0.0006 |
| 920 |
HYPOAESTHESIA |
89 |
0.0006 |
| 921 |
BLOOD GLUCOSE INCREASED |
112 |
0.0006 |
| 922 |
MUSCULOSKELETAL PAIN |
31 |
0.0006 |
| 923 |
PLASMA CELL MYELOMA |
23 |
0.0006 |
| 924 |
MIGRAINE |
56 |
0.0006 |
| 925 |
UNRESPONSIVE TO STIMULI |
15 |
0.0006 |
| 926 |
HYPOACUSIS |
25 |
0.0006 |
| 927 |
IMPAIRED HEALING |
19 |
0.0006 |
| 928 |
NERVOUSNESS |
30 |
0.0006 |
| 929 |
LIP SWELLING |
19 |
0.0006 |
| 930 |
COGNITIVE DISORDER |
26 |
0.0006 |
| 931 |
PANIC ATTACK |
20 |
0.0005 |
| 932 |
BLINDNESS |
22 |
0.0005 |
| 933 |
VISION BLURRED |
74 |
0.0005 |
| 934 |
DISTURBANCE IN ATTENTION |
29 |
0.0005 |
| 935 |
DRUG EXPOSURE DURING PREGNANCY |
18 |
0.0005 |
| 936 |
BURNING SENSATION |
37 |
0.0005 |
| 937 |
ANGINA PECTORIS |
15 |
0.0005 |
| 938 |
RHEUMATOID ARTHRITIS |
59 |
0.0005 |
| 939 |
VISUAL ACUITY REDUCED |
17 |
0.0005 |
| 940 |
SKIN EXFOLIATION |
43 |
0.0005 |
| 941 |
HYPERHIDROSIS |
65 |
0.0005 |
| 942 |
PARAESTHESIA |
78 |
0.0005 |
| 943 |
EYE DISORDER |
16 |
0.0005 |
| 944 |
OCULAR HYPERAEMIA |
23 |
0.0005 |
| 945 |
AGGRESSION |
24 |
0.0005 |
| 946 |
ROAD TRAFFIC ACCIDENT |
20 |
0.0005 |
| 947 |
ADVERSE EVENT |
44 |
0.0005 |
| 948 |
CARDIAC DISORDER |
44 |
0.0005 |
| 949 |
THERAPEUTIC RESPONSE UNEXPECTED |
21 |
0.0005 |
| 950 |
CONTRAINDICATED PRODUCT ADMINISTERED |
14 |
0.0005 |
| 951 |
ACNE |
35 |
0.0005 |
| 952 |
VAGINAL HAEMORRHAGE |
20 |
0.0005 |
| 953 |
CEREBROVASCULAR ACCIDENT |
78 |
0.0005 |
| 954 |
DYSGEUSIA |
34 |
0.0005 |
| 955 |
EYE SWELLING |
17 |
0.0005 |
| 956 |
LIMB DISCOMFORT |
14 |
0.0005 |
| 957 |
INJURY |
31 |
0.0004 |
| 958 |
MOVEMENT DISORDER |
14 |
0.0004 |
| 959 |
MYOCARDIAL INFARCTION |
76 |
0.0004 |
| 960 |
INJECTION SITE ERYTHEMA |
54 |
0.0004 |
| 961 |
INTENTIONAL PRODUCT MISUSE |
37 |
0.0004 |
| 962 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
30 |
0.0004 |
| 963 |
IRRITABILITY |
25 |
0.0004 |
| 964 |
TRANSIENT ISCHAEMIC ATTACK |
14 |
0.0004 |
| 965 |
MEDICATION ERROR |
23 |
0.0004 |
| 966 |
INJECTION SITE MASS |
15 |
0.0004 |
| 967 |
HOT FLUSH |
30 |
0.0004 |
| 968 |
OSTEONECROSIS |
13 |
0.0004 |
| 969 |
INJECTION SITE HAEMORRHAGE |
30 |
0.0004 |
| 970 |
SUICIDAL IDEATION |
34 |
0.0004 |
| 971 |
INCORRECT DOSE ADMINISTERED |
84 |
0.0004 |
| 972 |
DERMATITIS ATOPIC |
19 |
0.0004 |
| 973 |
PSORIASIS |
47 |
0.0004 |
| 974 |
DEVICE MALFUNCTION |
24 |
0.0003 |
| 975 |
LUNG NEOPLASM MALIGNANT |
14 |
0.0003 |
| 976 |
INJECTION SITE PAIN |
103 |
0.0003 |
| 977 |
PSORIATIC ARTHROPATHY |
13 |
0.0003 |
| 978 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
64 |
0.0003 |
| 979 |
INJECTION SITE BRUISING |
25 |
0.0003 |
| 980 |
PRODUCT SUBSTITUTION ISSUE |
18 |
0.0003 |
| 981 |
ARTHROPATHY |
17 |
0.0003 |
| 982 |
NO ADVERSE EVENT |
54 |
0.0003 |
| 983 |
DRUG EFFECT DECREASED |
16 |
0.0003 |
| 984 |
EMOTIONAL DISTRESS |
30 |
0.0002 |
| 985 |
INJECTION SITE REACTION |
17 |
0.0002 |
| 986 |
OVERDOSE |
53 |
0.0002 |
| 987 |
INJECTION SITE SWELLING |
18 |
0.0002 |
| 988 |
SKIN BURNING SENSATION |
16 |
0.0002 |
| 989 |
DEVICE ISSUE |
20 |
0.0002 |
| 990 |
PRODUCT QUALITY ISSUE |
28 |
0.0002 |
| 991 |
PROSTATE CANCER |
14 |
0.0002 |
| 992 |
BREAST CANCER |
15 |
0.0002 |
| 993 |
ACCIDENTAL EXPOSURE TO PRODUCT |
16 |
0.0002 |